rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    BJDX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Bluejay Diagnostics Reports Third Quarter 2026 Financial Results and Provides Business Update
      Nov 12Yahoo FinanceBJDX
      Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
      Oct 30Yahoo FinanceBJDX
      Bluejay Diagnostics completes manufacturing site milestone
      Oct 13Investing.comBJDX
      Bluejay Achieves Toray Contractual Manufacturing Milestone, Advancing Supply-Chain Resilience and Commercialization Readiness
      Oct 13Yahoo FinanceBJDX
      Bluejay Diagnostics Advances Rapid Biomarker Testing For Sepsis Patients
      Oct 6Yahoo FinanceBJDX
      Bluejay Diagnostics Advances Rapid Biomarker Testing For Sepsis Patients - Bluejay Diagnostics (NASDAQ:BJ

      Bluejay Diagnostics released baseline data from its SYMON-II study, evaluating the IL-6 biomarker for mortality risk in sepsis patients.

      Oct 6BenzingaBJDX
      Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock
      Oct 6MorningstarBJDX
      Bluejay Diagnostics Federal Healthcare Partnership Builds Commercial Pathway Ahead of FDA Clearance

      The Lovell Government Services agreement establishes federal procurement infrastructure for the Symphony platform, but commercialization remains dependent on regulatory authorization. Key Investor TakeawaysBluejay Diagnostics (NASDAQ:BJDX) has formed a distribution, co-marketing and strategic partnership with Lovell Government Services targeting U.

      Sep 8Yahoo FinanceBJDX
      12 Health Care Stocks Moving In Tuesday's Pre-Market Session
      Sep 8BenzingaBJDXISPC
      Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets

      Partnership Establishes Federal Distribution and Co-Marketing Framework Across VA, DoD, Military Health Systems and Other Government Healthcare ChannelsACTON, Mass. and PENSACOLA, Fla., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company focused on improving patient outcomes through its Symphony™ near-patient diagnostic platform, and Lovell Government Services, Inc. (“Lovell”), a Service-Disabled Veteran-Owned Co

      Sep 8Yahoo FinanceBJDX

      This is the newest page. Registered accounts read further back.